BioCentury
ARTICLE | Company News

RedPath, PDI deal

December 22, 2014 8:00 AM UTC

PDI acquired molecular diagnostics company RedPath for $12 million up front plus undisclosed milestones and up to 1 million PDI shares tied to the launch of a Barrett’s esophagus test. The terms of th...